Page 2 - FSANZ SPRING -2021

PBS listed for
ART
- Authority required (streamlined) 4997 200mg daily or up to 400mg twice a day
Prevention of preterm birth
- Authority required (streamlined) 11673 200mg daily from 16 weeks gestation
Halal Vegan
NEW CONSULTATION TOOL
HOW TO USE
ORIPRO VIDEO
Plant based
Natural micronised progesterone pessary
Scan the QR code and save the link to your browser!
NEW
PBS LISTING
FOR
PREVENTION
OF
PRETERM BIRTH*
*ORIPRO® is indicated for (1) Assisted Reproductive Technology (ART) treatment of infertile women with progesterone deficiency, requiring progesterone supplementation or replacement to support embryo implantation and maintain initial pregnancy, (2) Prevention of preterm birth in singleton pregnancies at risk due to; shortened cervix (midtrimester sonographic cervix ≤25mm) and/or where there is a history of spontaneous preterm birth.
PLEASE REVIEW THE FULL PRODUCT INFORMATION (PI) AVAILABLE HERE BEFORE RECOMMENDING.
ORIPRO® is a registered trademark of Orion Laboratories Pty Ltd trading as Perrigo Australia. ABN 56 009 293 136. 25–29 Delawney Street, Balcatta, Western Australia, 6021, AUSTRALIA. https://www.perrigo.com.au. For Medical Information enquiries: 1800 805 546 or AUMedicalInformation@perrigo.com. To report an adverse event: 1800 805 546, https://www.perrigo.com.au/contact/ or via free fax: 1800 004 110. (2109-ORI-243) Date prepared September 2021.
PBS Information: Authority required (STREAMLINED) for Assisted Reproductive Technology. Refer to PBS schedule for full authority information. Authority required (STREAMLINED) for Prevention of Preterm Birth in patients with a singleton pregnancy AND at least one of: (i) short cervix (mid-trimester sonographic cervix no greater than 25 mm), (ii) a history of spontaneous preterm birth.